CD133, also known as prominin-1, is a pivotal five-transmembrane domain cell-surface glycoprotein that serves as a key biomarker for the identification and isolation of a particular subpopulation referred to as “cancer stem-like cells” across various neoplasms, including breast cancer22. The gene discussed is PROM1; the disease is neoplasm.